ADIAL PHARMACEUTICALS, INC.
Close on Oct 19, 2026
- Market cap
- $16.73M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 13, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 17, 2026 | Before market open | – | $-11.25 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 11, 2026 | Before market open | – | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 6, 2026 | Before market open | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 14, 2025 | Before market open | – | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 14, 2025 | Before market open | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 15, 2025 | Before market open | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 4, 2025 | Before market open | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Nov 14, 2023 | After market close | – | – | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 21, 2023 | Before market open | – | – | – |
| Q1 FY2023 Ended Mar 31, 2023 | May 12, 2023 | After market close | – | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 31, 2023 | Before market open | – | – | – |
Press releases
Announcements Adial Pharmaceuticals filed with the SEC
UNAUDITED PRO FORMA CONDENSED BALANCE SHEET OF ADIAL PHARMACEUTICALS, INC. FOR THE QUARTER ENDED JUNE 30, 2026
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED AUGUST 17, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED ON JUNE 11, 2026
Material agreement · Acquisition or disposition completed · New financial obligation · Unregistered share sale · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
INVESTOR PRESENTATION, DATED JUNE 2026
Material agreement · Acquisition or disposition completed · New financial obligation · Unregistered share sale · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON MAY 11, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC., MARCH 6, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC., MARCH 3, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 3, 2026
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON NOVEMBER 26, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON NOVEMBER 14, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON SEPTEMBER 16, 2025
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON AUGUST 14, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED JUNE 17, 2025
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC., DATED MAY 15, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON MAY 2, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON MARCH 4, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC., FEBRUARY 25, 2025
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
BUSINESS DEVELOPMENT PRESENTATION OF ADIAL PHARMACEUTICALS, INC., DATED JANUARY 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
CORPORATE PRESENTATION OF ADIAL PHARMACEUTICALS, INC., DATED JANUARY 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC., NOVEMBER 14, 2024
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON MARCH 1, 2024
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON NOVEMBER 14, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON OCTOBER 20, 2023
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON OCTOBER 24, 2023
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
REVISED SECTIONS OF THE 2022 FORM 10-K
Other events · EX-99.1 to Form 8-K
ADIAL PHARMACEUTICALS, INC. INVESTOR PRESENTATION, DATED SEPTEMBER 11, 2023
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON AUGUST 21, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 4, 2023
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
ADIAL PHARMACEUTICALS, INC. INVESTOR PRESENTATION DATED JUNE 9, 2023
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON MAY 12, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC., DATED MARCH 30, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC.
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
ADIAL PHARMACEUTICALS, INC. PRESS RELEASE DATED MARCH 6, 2023
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
ADIAL PHARMACEUTICALS, INC. INVESTOR PRESENTATION DATED MARCH 7, 2023
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 24, 2023
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K